Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Right ventricular failure in congenital heart disease

  • Cho, Young Kuk (Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School) ;
  • Ma, Jae Sook (Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School)
  • Received : 2012.08.16
  • Accepted : 2012.11.14
  • Published : 2013.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Despite developments in surgical techniques and other interventions, right ventricular (RV) failure remains an important clinical problem in several congenital heart diseases (CHD). RV function is one of the most important predictors of mortality and morbidity in patients with CHD. RV failure is a progressive disorder that begins with myocardial injury or stress, neurohormonal activation, cytokine activation, altered gene expression, and ventricular remodeling. Pressure-overload RV failure caused by RV outflow tract obstruction after total correction of tetralogy of Fallot, pulmonary stenosis, atrial switch operation for transposition of the great arteries, congenitally corrected transposition of the great arteries, and systemic RV failure after the Fontan operation. Volume-overload RV failure may be caused by atrial septal defect, pulmonary regurgitation, or tricuspid regurgitation. Although the measurement of RV function is difficult because of many reasons, the right ventricle can be evaluated using both imaging and functional modalities. In clinical practice, echocardiography is the primary mode for the evaluation of RV structure and function. Cardiac magnetic resonance imaging is increasingly used for evaluating RV structure and function. A comprehensive evaluation of RV function may lead to early and optimal management of RV failure in patients with CHD.

Keywords

References

  1. Davlouros PA, Niwa K, Webb G, Gatzoulis MA. The right ventricle in congenital heart disease. Heart 2006;92 Suppl 1:i27-38. https://doi.org/10.1136/hrt.2005.077438
  2. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006;114:1883-91. https://doi.org/10.1161/CIRCULATIONAHA.106.632208
  3. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008;117:1436-48. https://doi.org/10.1161/CIRCULATIONAHA.107.653576
  4. Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg 2009;108:407-21. https://doi.org/10.1213/ane.0b013e31818f8623
  5. Ho SY, Nihoyannopoulos P. Anatomy, echocardiography, and normal right ventricular dimensions. Heart 2006;92 Suppl 1:i2-13. https://doi.org/10.1136/hrt.2005.077875
  6. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7-21. https://doi.org/10.3109/10976649909080829
  7. Kvasnicka J, Vokrouhlický L. Heterogeneity of the myocardium. Function of the left and right ventricle under normal and pathological conditions. Physiol Res 1991;40:31-7.
  8. Petitjean C, Rougon N, Cluzel P. Assessment of myocardial function: a review of quantification methods and results using tagged MRI. J Cardiovasc Magn Reson 2005;7:501-16. https://doi.org/10.1081/JCMR-200053610
  9. Dell'Italia LJ. Mechanism of postextrasystolic potentiation in the right ventricle. Am J Cardiol 1990;65:736-41. https://doi.org/10.1016/0002-9149(90)91380-O
  10. Goldstein JA, Barzilai B, Rosamond TL, Eisenberg PR, Jaffe AS. Determinants of hemodynamic compromise with severe right ventricular infarction. Circulation 1990;82:359-68. https://doi.org/10.1161/01.CIR.82.2.359
  11. Feneley MP, Gavaghan TP, Baron DW, Branson JA, Roy PR, Morgan JJ. Contribution of left ventricular contraction to the generation of right ventricular systolic pressure in the human heart. Circulation 1985;71:473-80. https://doi.org/10.1161/01.CIR.71.3.473
  12. Santamore WP, Dell'Italia LJ. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Prog Cardiovasc Dis 1998;40:289-308. https://doi.org/10.1016/S0033-0620(98)80049-2
  13. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. Am J Respir Crit Care Med 1994;150: 833-52. https://doi.org/10.1164/ajrccm.150.3.8087359
  14. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005;16:13-8. https://doi.org/10.1097/00019501-200502000-00003
  15. Dell'Italia LJ. The right ventricle: anatomy, physiology, and clinical importance. Curr Probl Cardiol 1991;16:653-720.
  16. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation 2006;114:1417-31. https://doi.org/10.1161/CIRCULATIONAHA.104.503540
  17. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation 2004;109:1580-9. https://doi.org/10.1161/01.CIR.0000120390.68287.BB
  18. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008;117:1717-31. https://doi.org/10.1161/CIRCULATIONAHA.107.653584
  19. Marino TA, Kent RL, Uboh CE, Fernandez E, Thompson EW, Cooper G 4th. Structural analysis of pressure versus volume overload hypertrophy of cat right ventricle. Am J Physiol 1985;249(2 Pt 2): H371-9.
  20. Kasimir MT, Seebacher G, Jaksch P, Winkler G, Schmid K, Marta GM, et al. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg 2004;26:776-81. https://doi.org/10.1016/j.ejcts.2004.05.057
  21. Graham TP Jr. Ventricular performance in congenital heart disease. Circulation 1991;84:2259-74. https://doi.org/10.1161/01.CIR.84.6.2259
  22. Currie PJ, Hagler DJ, Seward JB, Reeder GS, Fyfe DA, Bove AA, et al. Instantaneous pressure gradient: a simultaneous Doppler and dual catheter correlative study. J Am Coll Cardiol 1986;7:800-6. https://doi.org/10.1016/S0735-1097(86)80339-4
  23. Warnes CA. Transposition of the great arteries. Circulation 2006; 114:2699-709. https://doi.org/10.1161/CIRCULATIONAHA.105.592352
  24. Millane T, Bernard EJ, Jaeggi E, Howman-Giles RB, Uren RF, Cartmill TB, et al. Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries. J Am Coll Cardiol 2000;35:1661-8. https://doi.org/10.1016/S0735-1097(00)00585-4
  25. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, Pennell DJ, et al. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation 2005;111:2091-8. https://doi.org/10.1161/01.CIR.0000162463.61626.3B
  26. van Son JA, Danielson GK, Huhta JC, Warnes CA, Edwards WD, Schaff HV, et al. Late results of systemic atrioventricular valve replacement in corrected transposition. J Thorac Cardiovasc Surg 1995;109:642-52. https://doi.org/10.1016/S0022-5223(95)70345-4
  27. Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation 2006;114:1645-53. https://doi.org/10.1161/CIRCULATIONAHA.105.592055
  28. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005;95:779-82. https://doi.org/10.1016/j.amjcard.2004.11.037
  29. Cullen S, Shore D, Redington A. Characterization of right ventricular diastolic performance after complete repair of tetralogy of Fallot. Restrictive physiology predicts slow postoperative recovery. Circulation 1995;91:1782-9. https://doi.org/10.1161/01.CIR.91.6.1782
  30. Gatzoulis MA, Clark AL, Cullen S, Newman CG, Redington AN. Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance. Circulation 1995;91:1775-81. https://doi.org/10.1161/01.CIR.91.6.1775
  31. Messika-Zeitoun D, Thomson H, Bellamy M, Scott C, Tribouilloy C, Dearani J, et al. Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets. J Thorac Cardiovasc Surg 2004;128:296-302. https://doi.org/10.1016/j.jtcvs.2004.01.035
  32. Haddad F, Denault AY, Couture P, Cartier R, Pellerin M, Levesque S, et al. Right ventricular myocardial performance index predicts perioperative mortality or circulatory failure in high-risk valvular surgery. J Am Soc Echocardiogr 2007;20:1065-72. https://doi.org/10.1016/j.echo.2007.02.017
  33. Carabello BA. Evolution of the study of left ventricular function: everything old is new again. Circulation 2002;105:2701-3. https://doi.org/10.1161/01.CIR.0000021240.86593.9D
  34. Yu CM, Sanderson JE, Chan S, Yeung L, Hung YT, Woo KS. Right ventricular diastolic dysfunction in heart failure. Circulation 1996; 93:1509-14. https://doi.org/10.1161/01.CIR.93.8.1509
  35. Yap LB, Mukerjee D, Timms PM, Ashrafian H, Coghlan JG. Natriuretic peptides, respiratory disease, and the right heart. Chest 2004;126:1330-6. https://doi.org/10.1378/chest.126.4.1330
  36. Oosterhof T, Tulevski II, Vliegen HW, Spijkerboer AM, Mulder BJ. Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am J Cardiol 2006;97:1051-5. https://doi.org/10.1016/j.amjcard.2005.10.047
  37. Konstantinides S, Geibel A, Olschewski M, Kasper W, Hruska N, Jackle S, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002;106:1263-8. https://doi.org/10.1161/01.CIR.0000028422.51668.A2
  38. Torbicki A, Kurzyna M, Kuca P, Fijałkowska A, Sikora J, Florczyk M, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003;108:844-8. https://doi.org/10.1161/01.CIR.0000084544.54513.E2
  39. Landzberg MJ. Congenital heart disease associated pulmonary arterial hypertension. Clin Chest Med 2007;28:243-53, x. https://doi.org/10.1016/j.ccm.2006.12.004
  40. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease--longterm follow-up and prediction of outcome after surgical correction. Circulation 1987;76:1037-42. https://doi.org/10.1161/01.CIR.76.5.1037
  41. Inglessis I, Shin JT, Lepore JJ, Palacios IF, Zapol WM, Bloch KD, et al. Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock. J Am Coll Cardiol 2004;44:793-8. https://doi.org/10.1016/j.jacc.2004.05.047
  42. Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126(1 Suppl):35S-62S. https://doi.org/10.1378/chest.126.1_suppl.35S
  43. Gavazzi A, Ghio S, Scelsi L, Campana C, Klersy C, Serio A, et al. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension. Am Heart J 2003;145:310-6. https://doi.org/10.1067/mhj.2003.146
  44. Vizza CD, Rocca GD, Roma AD, Iacoboni C, Pierconti F, Venuta F, et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care 2001; 5:355-61. https://doi.org/10.1186/cc1069
  45. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005;46:2277-83. https://doi.org/10.1016/j.jacc.2005.05.096
  46. Massie B, Kramer BL, Topic N, Henderson SG. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise. Circulation 1982;65:1374-81. https://doi.org/10.1161/01.CIR.65.7.1374
  47. Quaife RA, Christian PE, Gilbert EM, Datz FL, Volkman K, Bristow MR. Effects of carvedilol on right ventricular function in chronic heart failure. Am J Cardiol 1998;81:247-50. https://doi.org/10.1016/S0002-9149(97)00874-6
  48. Dore A, Houde C, Chan KL, Ducharme A, Khairy P, Juneau M, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebocontrolled clinical trial. Circulation 2005;112:2411-6. https://doi.org/10.1161/CIRCULATIONAHA.105.543470

Cited by

  1. Echocardiography in children with Down syndrome vol.2, pp.4, 2013, https://doi.org/10.5409/wjcp.v2.i4.36
  2. The Dark Side of the Moon: The Right Ventricle vol.4, pp.4, 2013, https://doi.org/10.3390/jcdd4040018
  3. Tei Index Is the Best Echocardiographic Parameter for Assessing Right Ventricle Function in Patients With Unrepaired Congenital Heart Diseases With Outflow Tract Obstruction vol.6, pp.None, 2013, https://doi.org/10.3389/fped.2018.00181
  4. Transcatheter pulmonary balloon valvuloplasty of severe valvar pulmonary stenosis and atrial septal defect in patient with severe cyanosis and very low ventricle ejection fractions: a bailout procedur vol.31, pp.12, 2013, https://doi.org/10.1017/s1047951121001967